Evidence map›Paper›PMID 34122973›Full record

ArticleChemical science2020

Introduction of a 7-aza-6-MeO-indoline auxiliary in Lewis-acid/photoredox cooperative catalysis: highly enantioselective aminomethylation of α,β-unsaturated amides.

Santosh K Pagire, Naoya Kumagai, Masakatsu Shibasaki

Abstract read
In one paragraph

Article in Chemical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Enantioselective Giese Additions of Prochiral α-Amino Radicals.Journal of the American Chemical Society · 2022
    Article
  5. Article
  6. Recent developments in enantioselective photocatalysis.Beilstein journal of organic chemistry · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Santosh K PagireInstitute of Microbial Chemistry (BIKAKEN) 3-14-23, Kamiosaki Shinagawa-ku Tokyo 141-0021 Japan mshibasa@bikaken.or.jp nkumagai@bikaken.or.jp.ORCID https://orcid.org/0000-0002-8917-4933
Naoya KumagaiInstitute of Microbial Chemistry (BIKAKEN) 3-14-23, Kamiosaki Shinagawa-ku Tokyo 141-0021 Japan mshibasa@bikaken.or.jp nkumagai@bikaken.or.jp.ORCID https://orcid.org/0000-0003-1843-2592
Masakatsu ShibasakiInstitute of Microbial Chemistry (BIKAKEN) 3-14-23, Kamiosaki Shinagawa-ku Tokyo 141-0021 Japan mshibasa@bikaken.or.jp nkumagai@bikaken.or.jp.ORCID https://orcid.org/0000-0001-8862-582X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An efficient cooperative chiral Lewis acid/photoredox catalytic system for engaging highly reactive radicals in highly enantioselective conjugate addition to α,β-unsaturated carbonyls is highly desirable. Direct photoexcitation of unbound substrates typically induces undesired background pathways for racemic products and remains a formidable challenge to be addressed in the area of enantioselective photocatalysis. Herein, we report a cooperative catalytic system comprising a chiral Cu(i) complex and an Ir(iii) photocatalyst fueled by visible-light irradiation that allows for seamless integration of the catalytic formation of α-amino alkyl radicals and subsequent enantioselective addition to α,β-unsaturated amides. A 7-aza-6-MeO-indoline attachment on the amide substrates plays a pivotal role in suppressing the undesired pathways, resulting in excellent enantioselectivity and enabling expedited access to valuable γ-aminobutyramides. The indoline amide was readily diversified with full recovery of the azaindoline attachment, highlighting the synthetic utility of this cooperative catalytic system.

Identifiers

PMID34122973
PMCPMC8159422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.